On January 30, 2026, the Economic Observer successfully held the 2025 Innovation Summit. Centered around the theme “New Quality Leading the Way, Innovation Opening the Future,” the summit brought together numerous entrepreneurs, scholars, and industry leaders. They shared cutting-edge developments and innovative practices in trending fields such as artificial intelligence, digital transformation, robotics, and biopharmaceuticals.

As global industrial competition enters a new phase of “innovation racing and cluster breakthroughs,” “new quality productive forces” have become a core engine driving high-quality economic development in China. With the upcoming 15th Five-Year Plan, future industries such as artificial intelligence, semiconductor chips, robotics, aerospace economy, and biopharmaceuticals are rapidly reshaping the national competitive landscape.

This summit anchored on the “New Quality 100” enterprise innovation cluster, focusing on strategic emerging industries such as artificial intelligence, semiconductors, and biopharmaceuticals. It aimed to identify innovative forces that drive industrial upgrading through breakthroughs in core technologies and represent the direction of China’s new quality productive forces. At the event, the much-anticipated “2025 New Quality 100 Innovative Enterprises List” was officially unveiled. Biokin Pharmaceutical successfully made it onto the list, becoming a benchmark enterprise for new quality productive forces empowering the development of the real economy.